pocketful logo
Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

NSE: TORNTPHARM BSE: 500420

₹4270.20

(1.41%)

Mon, 23 Mar 2026, 01:58 pm

mtf coin illustrationMTF 5x

Torrent Pharmaceuticals Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    144440.05

  • Net Profit

    1911.25

  • P/B

    14.42

  • Sector P/E

    31.86

  • P/E

    57.28

  • EV/EBITDA

    30.13

  • Debt/Equity (Industry)

    0.25

  • Interest Cover (Industry)

    11.42

  • ROCE (Industry)

    16.55

  • RONW (Industry)

    14.50

  • ROE

    26.46

  • ROCE

    25.84

  • Debt/Equity

    0.50

  • EPS (TTM)

    68.12

  • Dividend Yield

    0.14

  • Book Value

    249.65

  • Interest Cover

    11.59

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are well covered by earnings (3.6x coverage).
  • Dividends after 3 years are expected to be well covered by earnings (3x coverage).
  • Cash flow for Torrent Pharmaceuticals is expected to increase by more than 50% in 2 years time.
  • Torrent Pharmaceuticals's earnings growth is expected to exceed the low risk savings rate of 7.2%.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Torrent Pharmaceuticals's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Torrent Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • Torrent Pharmaceuticals's earnings are expected to grow by 16.6% yearly, however this is not considered high growth (20% yearly).
  • Torrent Pharmaceuticals's earnings growth is positive but not above the India market average.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters68.3168.3168.3168.3168.31
FII16.1315.9216.0916.3116.17
DII9.149.288.658.358.35
Public6.426.496.947.037.17
Government0.000.000.000.000.00

Read More

Technical Analysis

RSI

45.74

MACD

25.87

50 DMA

4160.81

200 DMA

3732.52

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic5367.934801.834567.574235.734001.473669.633103.53
Fibonacci4801.834585.584451.984235.734019.483885.883669.63
Camarilla4488.984437.094385.194235.734281.414229.524177.62

Pivots Level: Classic

R3

+1132.20

5367.93

R2

+566.10

4801.83

R1

+331.83

4567.57

4235.73
4235.73
Pivot Point
LTP: 4213.90

S1

-234.27

4001.47

S2

-566.10

3669.63

S3

-1132.20

3103.53

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    4290.35

  • 20-EMA

    4288.33

  • 30-EMA

    4254.44

  • 50-EMA

    4175.14

  • 100-EMA

    4012.21

  • 200-EMA

    3794.67

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
13 Feb 2026board-meetingsQuarterly Results, Interim Dividend
13 Feb 2026dividend₹29.00 Dividend /Share19 Feb 2026
18 Jan 2026dividendInterim Dividend - Rs 29 Per Share19 Feb 2026
07 Nov 2025board-meetingsQuarterly Results
04 Jul 2025agm
20 May 2025dividend₹6.00 Dividend /Share20 Jun 2025
24 Jan 2025dividend₹26.00 Dividend /Share01 Feb 2025
01 Jan 2025dividendInterim Dividend - Rs. - 2601 Feb 2025
31 Dec 2024dividendInterim Dividend - Rs 26 Per Sh01 Feb 2025
25 Jun 2024agm

Read More

Peer Comparison

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Lupin Ltd logo

Lupin Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Torrent Pharmaceuticals Ltd About

Torrent Pharmaceuticals is engaged in manufacturing, developing and marketing of generic pharmaceutical formulations.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1972

Headquarters

CEO

Samir Mehta

Employees

Contact

Website icon

Website

http://www.torrentpharma.com

Email icon

Email

investorservices@torrentpharma.com

Phone icon

Phone

91-79-26599000

Location icon

Location

Torrent House, Off Ashram Road, Ahmedabad, Gujarat, 380009

Read More

Torrent Pharmaceuticals Ltd Company History

YearHistory
2019
  • Amended AOA/MOA.
  • Signed licensing agreement with Glenmark for co-marketing Remogliflozin Etabonate.
  • Changed Registrar & Share Transfer Agent to KFIN TECHNOLOGIES PRIVATE LIMITED.
2021
  • USFDA inspection at Levittown manufacturing facility.
  • Introduced molnupiravir as Molnutor®.
  • Entered Voluntary Licensing Agreement with Lilly for Baricitinib for Covid-19.
2022
  • Acquired 100% stake in Curatio Health Care Private Limited.
  • Recommended bonus shares in 1:1 ratio.
2023
  • Signed licensing agreement with Zydus for co-marketing Saroglitazar Mg.
  • Started construction of Virochannagar manufacturing facility.
  • Received EIR from US FDA for Dahej facility.
2024
  • Entered into Non-Exclusive Patent Licensing Agreement with Takeda Pharmaceuticals for novel GI drug.
  • Commissioned subsidiaries in Colombia and Chile.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
TORRENT INVESTMENTS PRIVATE LIMITEDSell49720203104.430 Oct 2024
TORRENT INVESTMENTS PRIVATE LIMITEDSell49720203103.0730 Oct 2024
INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.Sell11496692365.3229 May 2020
BLACKROCK ADVISORS LLC A/C THE MASTER TRUST BANK OF JAPAN LBuy20406232367.229 May 2020
LAVENDER INVESTMENTS LIMITEDSell9012071475.0815 Jun 2018
MEHTA SAPNA SAMIRSell8858864144029 Mar 2017
TORRENT PRIVATE LIMITEDBuy8858864144029 Mar 2017
TORRENT PRIVATE LIMITEDBuy5885276140128 Mar 2017
VARUN SUDHIRBHAI MEHTASell1749900140128 Mar 2017
TORRENT PRIVATE LIMITEDBuy19704108140128 Mar 2017

Read More

Torrent Pharmaceuticals Ltd News

Torrent Pharma Launches Semaglutide Brands in India

Torrent Pharmaceuticals launches Sembolic and Semalix semaglutide brands in oral and injectable formulations, becoming first Indian company to offer generic oral semaglutide at ₹3,999 monthly pricing.

23 Mar 2026

companies

Torrent Pharma Launches Semaglutide Brands in India

Torrent Pharmaceuticals launches Sembolic and Semalix semaglutide brands in oral and injectable formulations, becoming first Indian company to offer generic oral semaglutide at ₹3,999 monthly pricing.

21 Mar 2026

companies

Torrent Pharma Launches Generic Semaglutide in India

Torrent Pharmaceuticals becomes first Indian company to launch generic oral semaglutide formulation alongside injectable version priced at ₹3,999 monthly, marking significant diabetes treatment milestone.

21 Mar 2026

companies

Torrent Pharma Q3FY26 Revenue Jumps 18% to ₹3,303 Cr

Torrent Pharmaceuticals reports strong Q3FY26 performance with total revenue growing 18% YoY to ₹3,303 crores, driven by robust growth across India, US, and Brazil markets.

13 Feb 2026

co actions results

Torrent Pharma Completes JB Chemicals Acquisition

Torrent Pharmaceuticals has completed its acquisition of JB Chemicals shares, now holding 48.80% stake with 7,83,57,892 equity shares after acquiring final 92,490 shares from employee.

03 Feb 2026

co actions results

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800